Logo image of LFWD

LIFEWARD LTD (LFWD) Stock Fundamental Analysis

NASDAQ:LFWD - Nasdaq - IL0011331076 - Common Stock - Currency: USD

2.44  +0.57 (+30.48%)

Fundamental Rating

3

LFWD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. The financial health of LFWD is average, but there are quite some concerns on its profitability. LFWD is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LFWD has reported negative net income.
LFWD had a negative operating cash flow in the past year.
In the past 5 years LFWD always reported negative net income.
LFWD had a negative operating cash flow in each of the past 5 years.
LFWD Yearly Net Income VS EBIT VS OCF VS FCFLFWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -42.17%, LFWD is doing worse than 62.77% of the companies in the same industry.
LFWD's Return On Equity of -56.95% is in line compared to the rest of the industry. LFWD outperforms 47.34% of its industry peers.
Industry RankSector Rank
ROA -42.17%
ROE -56.95%
ROIC N/A
ROA(3y)-24.94%
ROA(5y)-36.97%
ROE(3y)-30.18%
ROE(5y)-58.88%
ROIC(3y)N/A
ROIC(5y)N/A
LFWD Yearly ROA, ROE, ROICLFWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -200 -400 -600 -800 -1K

1.3 Margins

LFWD's Gross Margin of 35.26% is on the low side compared to the rest of the industry. LFWD is outperformed by 70.21% of its industry peers.
LFWD's Gross Margin has declined in the last couple of years.
LFWD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.6%
GM growth 5Y-5.73%
LFWD Yearly Profit, Operating, Gross MarginsLFWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600

More info and screens

6

2. Health

2.1 Basic Checks

LFWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
LFWD has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, LFWD has more shares outstanding
LFWD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LFWD Yearly Shares OutstandingLFWD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
LFWD Yearly Total Debt VS Total AssetsLFWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

LFWD has an Altman-Z score of -7.30. This is a bad value and indicates that LFWD is not financially healthy and even has some risk of bankruptcy.
LFWD has a worse Altman-Z score (-7.30) than 74.47% of its industry peers.
LFWD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -7.3
ROIC/WACCN/A
WACC9.11%
LFWD Yearly LT Debt VS Equity VS FCFLFWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M 80M

2.3 Liquidity

LFWD has a Current Ratio of 2.65. This indicates that LFWD is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of LFWD (2.65) is comparable to the rest of the industry.
A Quick Ratio of 1.90 indicates that LFWD should not have too much problems paying its short term obligations.
LFWD has a Quick ratio of 1.90. This is comparable to the rest of the industry: LFWD outperforms 47.34% of its industry peers.
Industry RankSector Rank
Current Ratio 2.65
Quick Ratio 1.9
LFWD Yearly Current Assets VS Current LiabilitesLFWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.86% over the past year.
The Revenue has grown by 173.28% in the past year. This is a very strong growth!
Measured over the past years, LFWD shows a quite strong growth in Revenue. The Revenue has been growing by 16.18% on average per year.
EPS 1Y (TTM)3.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.54%
Revenue 1Y (TTM)173.28%
Revenue growth 3Y46.65%
Revenue growth 5Y16.18%
Sales Q2Q%39.18%

3.2 Future

The Earnings Per Share is expected to grow by 25.55% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 60.99% on average over the next years. This is a very strong growth
EPS Next Y33.9%
EPS Next 2Y30.1%
EPS Next 3Y27.69%
EPS Next 5Y25.55%
Revenue Next Year78.92%
Revenue Next 2Y62.53%
Revenue Next 3Y74.13%
Revenue Next 5Y60.99%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LFWD Yearly Revenue VS EstimatesLFWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M
LFWD Yearly EPS VS EstimatesLFWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 -200 -400 -600

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LFWD. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LFWD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LFWD Price Earnings VS Forward Price EarningsLFWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LFWD Per share dataLFWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

LFWD's earnings are expected to grow with 27.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.1%
EPS Next 3Y27.69%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LFWD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIFEWARD LTD

NASDAQ:LFWD (2/11/2025, 11:24:06 AM)

2.44

+0.57 (+30.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)02-20 2025-02-20/amc
Inst Owners21.65%
Inst Owner ChangeN/A
Ins Owners2.77%
Ins Owner Change49.08%
Market Cap21.50M
Analysts82.5
Price Target9.69 (297.13%)
Short Float %3.14%
Short Ratio0.77
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.97%
Min EPS beat(2)-8.93%
Max EPS beat(2)10.87%
EPS beat(4)1
Avg EPS beat(4)-6.94%
Min EPS beat(4)-27.45%
Max EPS beat(4)10.87%
EPS beat(8)2
Avg EPS beat(8)-8.44%
EPS beat(12)2
Avg EPS beat(12)-22.54%
EPS beat(16)4
Avg EPS beat(16)-18.31%
Revenue beat(2)0
Avg Revenue beat(2)-15.04%
Min Revenue beat(2)-28.9%
Max Revenue beat(2)-1.18%
Revenue beat(4)0
Avg Revenue beat(4)-10.83%
Min Revenue beat(4)-28.9%
Max Revenue beat(4)-1.18%
Revenue beat(8)2
Avg Revenue beat(8)-10.02%
Revenue beat(12)2
Avg Revenue beat(12)-21.48%
Revenue beat(16)5
Avg Revenue beat(16)-14.25%
PT rev (1m)0%
PT rev (3m)-11.63%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.62%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-30.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-16.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.86
P/FCF N/A
P/OCF N/A
P/B 0.63
P/tB 1.32
EV/EBITDA N/A
EPS(TTM)-2.49
EYN/A
EPS(NY)-0.88
Fwd EYN/A
FCF(TTM)-2.53
FCFYN/A
OCF(TTM)-2.52
OCFYN/A
SpS2.84
BVpS3.85
TBVpS1.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -42.17%
ROE -56.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.26%
FCFM N/A
ROA(3y)-24.94%
ROA(5y)-36.97%
ROE(3y)-30.18%
ROE(5y)-58.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.6%
GM growth 5Y-5.73%
F-Score3
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.07%
Cap/Sales 0.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.65
Quick Ratio 1.9
Altman-Z -7.3
F-Score3
WACC9.11%
ROIC/WACCN/A
Cap/Depr(3y)11.48%
Cap/Depr(5y)13.38%
Cap/Sales(3y)0.61%
Cap/Sales(5y)0.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.54%
EPS Next Y33.9%
EPS Next 2Y30.1%
EPS Next 3Y27.69%
EPS Next 5Y25.55%
Revenue 1Y (TTM)173.28%
Revenue growth 3Y46.65%
Revenue growth 5Y16.18%
Sales Q2Q%39.18%
Revenue Next Year78.92%
Revenue Next 2Y62.53%
Revenue Next 3Y74.13%
Revenue Next 5Y60.99%
EBIT growth 1Y9.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-34.39%
OCF growth 3YN/A
OCF growth 5YN/A